HomeAbout UsSubscribeResources & ContentArchives Submissions Reprints & Back IssuesContact UsAdvertising

In the News

First Comprehensive Arthritis Data Report Available

Low-Fat Diet With Caloric Restriction Reduces White Matter Microglia Activation During Aging

Naturopathic Medicine is Growing in U.S. Medical Centers of Excellence

The Israeli Ministry of Health has Approved Kanabo Research's Medical Cannabis Vaporizer as a Medical Device

Released: 03/15/18

First Comprehensive Arthritis Data Report Available


CDC released the first comprehensive report of state-level estimates about adults with arthritis today, titled—Geographic Variations in Arthritis Prevalence, Health-Related Characteristics, and Management — United States, 2015.

This Morbidity and Mortality Weekly Report Surveillance Summary shows the differences in the impact of arthritis at the state level.  

The new arthritis report estimates the number and percentage of  adults with:

  • Arthritis in each state and Washington, DC.
  • Arthritis-attributable activity limitations.
  • Arthritis-attributable severe joint pain.
  • Arthritis and one or more other diseases, such as obesity, coronary heart disease, and diabetes.
  • Arthritis who are physically inactive.
  • Arthritis who were counseled by their health care provider to be physically active or to lose weight (13 states).
  • Arthritis who participated in self-management education workshops (13 states).
  • Arthritis who walk for exercise.

These estimates will enable CDC and other public health partners to move forward and better target the dissemination of evidenced-based interventions that can decrease the impact of arthritis, including easing arthritis pain. The data presented in this Surveillance Summary was collected as part of CDC’s Behavioral Risk Factor Surveillance System (BRFSS).


Released: 03/15/18

Low-Fat Diet With Caloric Restriction Reduces White Matter Microglia Activation During Aging

A low-fat diet in combination with limited caloric consumption prevents activation of the brain's immune cells -- called microglia -- in aging mice, shows research published recently in Frontiers in Molecular Neuroscience. The study also finds that exercise is significantly less effective than caloric restriction in preventing these age-related changes.

"Obesity and aging are both prevalent and increasing in societies worldwide, but the consequences for the central nervous system are not well understood," says Bart Eggen, lead author of the study and a researcher at the University Medical Center Groningen, The Netherlands. "We determined if a high- or low-fat diet, in combination with exercise and food restriction, impacted microglia during aging in mice."

Microglia are brain cells that help maintain the integrity and normal functioning of brain tissue. Dysfunction of these cells, as may occur in disease, is linked to neurodevelopmental disorders and neurodegenerative conditions. Aging is also associated with inflammation driven by microglia in specific regions of the brain, but it is unclear whether diet or lifestyle can influence this process.

Eggen and his collaborators investigated the impact of high- and low-fat diets on inflammation and microglial markers in a specific brain region -- the hypothalamus -- of 6-month-old mice. They further looked at the effect of low- or high-fat diets on the microglia of 2-year-old mice, which were also given a lifelong exercise regime (voluntary running wheel) or lifelong restricted diets (a 40% reduction in calories).

"Aging-induced inflammatory activation of microglia could only be prevented when mice were fed a low-fat diet in combination with limited caloric intake," says Eggen. "A low-fat diet per se was not sufficient to prevent these changes."

The researchers also found that exercise was significantly less effective than caloric restriction at preventing these changes, although work by others has shown that exercise is associated with reducing the risk of other diseases.

Eggen is careful to point out that there is still much more work needed to understand the meaning of these findings. In their study, mice were only given one type of diet throughout their lives. It remains unclear how changing between diets would alter these results -- for example whether switching to a low-fat diet could undo the negative consequences of a high-fat, unrestricted diet. Further studies are also needed to determine how these changes correspond to the cognitive performance of the mice.

"Nevertheless, these data do show that, in mice, the fat content of a diet is an important parameter in terms of the detrimental effects of aging on the brain, as well as caloric intake," says Eggen. "Only when fat content and caloric intake are limited, can aging-induced changes in microglia be prevented."


Story Source: Materials provided by Frontiers.


Released: 03/15/18

Naturopathic Medicine is Growing in U.S. Medical Centers of Excellence

 More Americans are seeking complementary and natural health care providers, as they focus on wellness, prevention, and whole-person care. Increasingly, consumers can find licensed naturopathic doctors as members of the professional clinical teams at medical centers of excellence around the United States. Twenty-eight prominent health systems, hospitals, and cancer treatment centers now have one or more licensed naturopathic doctors on staff at their facilities. Today there are approximately 6,000 licensed naturopathic doctors practicing in the U.S. Twenty-three U.S. states and territories currently license naturopathic doctors.

Trained to treat the whole person, naturopathic doctors diagnose, prevent and treat acute and chronic illness. Naturopathic doctors complete a rigorous, science-based, four-year, post-graduate education in an accredited naturopathic medical college, recognized by the United States Department of Education. Working as both primary care providers and members of collaborative integrative healthcare teams, naturopathic doctors address underlying causes of illness. Because of their rigorous training in clinical nutrition, lifestyle counseling, botanical medicine and more, they are experts at engaging and empowering patients to make lifestyle changes, proven to improve health outcomes.

"Naturopathic doctors are meeting the growing consumer demand for whole-body health care providers, and they are delivering better health outcomes at lower costs," said Michelle Simon, PhD, ND and Chair of the INM Board of Directors. "In addition to their ability to fill the growing shortage of primary care providers, NDs are sought out for complementary specialty care in oncology, gastroenterology, endocrinology, cardiology and other core fields."

Spanning academic, University-affiliated hospitals, integrative medical centers, large health systems, and specialty treatment centers, here are 28 medical centers of excellence with naturopathic doctors on staff:

Alliance Institute for Integrative Medicine

Amen Clinics Northwest

Beaumont Health System

Cancer Treatment Centers of America

Cedars-Sinai, Los Angeles

Columbia University, Herbert Irving Comprehensive Cancer Center

Fred Hutchinson Cancer Research Center

George Washington Center For Integrative Medicine

Goshen Center for Cancer Care

Hartford Hospital


Integrative Medical Group of Irvine

Lake Health Integrative Medicine

University of Kansas Medical Center

Maryland Proton Treatment Center

Northwestern Osher Center for Integrative Medicine

One Medical Integrative Health

Oregon Health Sciences University

Providence Integrative Medicine Program

Raby Institute for Integrative Medicine at Northwestern

Shawnee Mission Health

Tru Health Medicine

University Hospitals, Connor Integrative Health Network

University of Arizona Center for Integrative Medicine

University of California Irvine, Susan Samueli Center for Integrative Medicine

University of Washington Medical Center-Roosevelt

University of Wisconsin Integrative Health Clinic

University of Pittsburgh Medical Center for Integrative Medicine


About the Institute for Natural Medicine  
The Institute for Natural Medicine (INM) is a national not-for-profit 501(c)(3) organization that provides public education about naturopathic medicine and increases consumer access to naturopathic doctors. As a close partner to the American Association of Naturopathic Physicians, the INM strives to increase consumer and physician choice in safe, effective healthcare that improves patient outcomes and lowers costs. For more information visit www.naturemed.org or call 855-799-4490.


Released: 03/15/18

The Israeli Ministry of Health has Approved Kanabo Research's Medical Cannabis Vaporizer as a Medical Device

Kanabo Research, a Tel-Aviv-based medical cannabis R&D company, is pleased to announce that the Israeli Ministry of Health has granted initial approval as a medical device to its VapePod vaporizer product. This action makes Israel the first county in the world to grant medical device approval to a vaporizer for the use of medical cannabis extracts and formulations.

In addition, Kanabo has initiated initial pre-clinical trials of the company's targeted formulations for sleep disorders, designed for use with the approved VapePod medical cannabis vaporizer, and is achieving impressive results in early findings.

The combination of the approved vaporizer and the targeted formulations will enable medical cannabis patients to receive more effective, consistent, and accurate dosing and delivery methods than currently accepted medical cannabis treatment methods. Kanabo has two patents in the process of registration regarding the targeted formulations of medical cannabis extracts for sleep disorders, as well as the initial approval of the VapePod vaporizer by the Medical Cannabis Unit of the Israeli Ministry of Health.

Most medical cannabis patients today consume their cannabis by smoking - despite all of the known risks. The VapePod medical vaporizer enables patients to inhale their medical cannabis without the risks of smoking. Studies have shown that inhaling cannabis is significantly more effective than other delivery methods, and the VapePod vaporizer allows patients to still utilize the benefits of inhalation. The next version of the device - VapePod MD - will also monitor patient usage and gather usage data for caregivers, doctors, and research applications.

"This approval is a significant announcement for the medical cannabis patients in Israel who will be able to use the medical vaporizer for the first time," said Avihu Tamir, co-founder and CEO of Kanabo Research. "We expect that due to the transition of most of the cannabis consumers to the use of vaporizers, our company is projected to reach 10 million dollars in sales within three years in the Israeli market, while the Israeli cannabis market is expected to reach 100 million dollars in sales within three years. The Israeli market is a platform to deliver our technology to global markets in North America and Europe."


SOURCE Kanabo Research


All contents © Copyright -2018 Integrative Medicine A Clinicican's Journal. All rights reserved. Integrative Medicine A Clinicican's Journal is a registered trademark.
All rights reserved. Terms and Conditions.

Vital Choice-Your Trusted Source For The World's Finest Wild Seafood & Organic Fare - All With Free Shipping On Orders Over $99! Click Here!